Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 22.26 CNY -0.98% Market Closed
Market Cap: 12.6B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

Henan Lingrui Pharmaceutical Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Henan Lingrui Pharmaceutical Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Accounts Payable
ÂĄ91.2m
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
11%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Payable
ÂĄ163.8m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Payable
ÂĄ470.9m
CAGR 3-Years
23%
CAGR 5-Years
13%
CAGR 10-Years
19%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Payable
ÂĄ1.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Payable
ÂĄ4.5B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Payable
ÂĄ307.9m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Henan Lingrui Pharmaceutical Co Ltd
Glance View

Market Cap
12.5B CNY
Industry
Pharmaceuticals

Nestled in the heart of China's Henan province, Henan Lingrui Pharmaceutical Co Ltd has quietly crafted a legacy in the pharmaceutical sector, blending traditional Chinese medicine with modern medical practices. Founded in an environment rich in natural resources, the company takes pride in its extensive portfolio that includes a broad range of pharmaceutical products such as tablets, injections, ointments, and Chinese patent medicines. The company's approach is an intricate dance between ancient wisdom and contemporary science, where herbal remedies are often synthesized with cutting-edge pharmaceutical manufacturing processes. Priding itself on research and development, Lingrui regularly collaborates with esteemed medical institutions, ensuring that its offerings remain both innovative and deeply rooted in traditional therapeutic principles. The financial heartbeat of Henan Lingrui is sustained through a strategic balance of domestic sales and international exports, capitalizing on the rising global demand for natural and alternative medicines. As the company expands its footprint, it continues to harness its robust supply chain and distribution channels to seamlessly deliver its products to hospitals, pharmacies, and health institutions across various regions. Indeed, the harmonious blend of traditional and modern methodologies not only defines Lingrui's operations but also shapes its revenue streams. By adhering to stringent quality standards and fostering partnerships, Henan Lingrui Pharmaceutical not only thrives in its local market but also competes in diverse international arenas, leveraging its unique product offerings as a cornerstone for financial growth.

Intrinsic Value
32.69 CNY
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Henan Lingrui Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
91.2m CNY

Based on the financial report for Sep 30, 2024, Henan Lingrui Pharmaceutical Co Ltd's Accounts Payable amounts to 91.2m CNY.

What is Henan Lingrui Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
11%

Over the last year, the Accounts Payable growth was 22%. The average annual Accounts Payable growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 2% over the past three years , 15% over the past five years , and 11% over the past ten years .

Back to Top